Study Objectives: Rapid-eye-movement (REM) sleep without atonia (RSWA) is a marker of REM sleep behavior disorder (RBD) and is common in narcolepsy. Available techniques for electromyogram (EMG) analysis are species-specific, limiting translational research on RSWA. We developed an automated technique based on distributions of normalized EMG values (DNE) to overcome this limitation. With DNE, we tested whether the control of neck and tibialis anterior (TA) muscles during sleep in wild-type rats and mice validly models the control of submentalis (chin) and TA muscles in healthy humans. We then applied DNE to REM sleep recordings of patients with idiopathic RBD and of mouse models of narcolepsy, testing for a common DNE signature of RSWA. Methods: Retrospective analysis of sleep recordings from 20 idiopathic RBD patients, 34 control subjects, 8 wild-type rats, 21 orexin-neuron deficient mice, 8 orexin knock-out mice, and 22 wild-type mice. Results: Neck EMG of rats and mice and human chin EMG progressively decreased from wakefulness to non-REM sleep and REM sleep, whereas the effects of sleep on TA EMG differed between rats, mice, and humans. DNE discriminated idiopathic RBD patients from controls based on higher median values of normalized chin EMG during REM sleep. The same parameter, computed on neck muscle EMG, discriminated narcoleptic mice from wild-type mice. Conclusions: These results support the application of DNE in translational research on RSWA. Increased median values of normalized EMG of chin (humans) and neck (rats and mice) muscles may be a signature of RSWA in different species and pathological conditions.
INTRODUCTION
Muscle atonia is a hallmark of rapid-eye-movement (REM) sleep in physiological conditions. 1 The occurrence of REM sleep without atonia (RSWA) is, conversely, the typical polysomnographic marker of REM sleep behavior disorder (RBD) 2, 3 and is also common in patients with narcolepsy. 4, 5 Experiments on laboratory animals have been key to our current understanding of RSWA, RBD, and narcolepsy. RSWA and RBD were reported on cats with pontine lesions 6, 7 even earlier than on human patients. 2 Experiments on mice 8, 9 demonstrated that the loss of hypothalamic orexin (hypocretin) neurons, which occurs in patients with narcolepsy, 10 is sufficient to explain most if not all clinical signs of this disease. 3 The severity of RSWA in patients is quantified with visual [11] [12] [13] or automated [14] [15] [16] [17] analysis of submentalis (chin) and limb electromyographic (EMG) tracings. Indexes of RSWA based on neck, masseter, and hind limb EMG have also been computed on mice with impaired glycine and GABA A receptor function 18 and on rats with GABA B agonist injection in the inferior colliculus. 19 A key unresolved issue in these studies is whether the control of the neck EMG of rodents during sleep validly models the control of the chin EMG of humans during sleep, which is a mainstay of most clinical indexes of RSWA. [11] [12] [13] [14] [15] [16] Among the other muscles whose EMG discriminates patients with idiopathic RBD from control subjects, 12 only the tibialis anterior (TA) EMG is currently amenable to recordings in freely-behaving rats and mice. [18] [19] [20] The distribution of the time intervals between TA EMG bursts during non-rapid-eye-movement (NREM) sleep, which characterizes their time structure, is similar in healthy young human subjects, rats, and mice. 20 While this may be of interest for modeling the restless legs syndrome, the key unresolved issue at stake for modelling RSWA is whether the amplitude of TA EMG varies during sleep comparably in rodents and human subjects.
These considerations suggest that the bases of translational research on RSWA would be strengthened if the EMG amplitudes of different muscles of human subjects and animal models during sleep could be directly compared with a single analysis technique. Having cross-species comparable EMG signals would overcome difficulties in translating the severity of RSWA, which may stem from arbitrary definitions of REM sleep atonia for different muscles and species. This may benefit research on RSWA associated either with Parkinson's disease, the animal models of which have failed so far to replicate the characteristic pattern of sleep dysfunctions, 21 or with narcolepsy, the exact mechanisms of which are still unclear. Key to the technique to obtain cross-species comparable EMG signals should be a normalization procedure, which compensates for
Statement of Significance
Muscles generally lose their tone (atonia) during rapid-eye-movement (REM) sleep. The occurrence of REM sleep without atonia (RSWA) is the typical marker of REM sleep behavior disorder (RBD), a potential harbinger of neurodegeneration, and is also common in narcolepsy. The possibility to compare the activity of different muscles in different species with one technique would facilitate translational research on RSWA. In this study, we developed a novel, fully automated technique that realized this possibility. Application of this technique yielded an EMG signature of RSWA that was common to patients with idiopathic RBD and mouse models of narcolepsy, and that, therefore, may be relevant to different species and disease conditions. differences between muscles and species due to muscle size, EMG electrode position (skin vs. intramuscular) and conductance, and EMG signal conditioning. Ideally, this technique should also be automated, as a very wide expertise would be required for accurate manual review of EMG signals from different species.
We report hereafter the results of three connected studies, with the overarching aim to strengthen the bases for valid translational models of RSWA. In study 1, we developed a novel, fully automated technique for the analysis of distributions of normalized EMG values (DNE) during sleep, applicable to different muscles and species. With DNE, we tested whether the control of neck and TA muscles in wild-type rats and mice validly models the control of chin and TA muscles in healthy humans. In study 2, we then sought to obtain proof of principle that DNE is sensitive to RSWA in patients. As previously mentioned, RSWA is among the diagnostic criteria for RBD. 3 The idiopathic form of RBD is the most widely studied because it is a likely prodrome of a synucleopathy (Parkinson's disease, Lewy Body disease or multiple system atrophy), thus marking a potential early window for neuroprotection. 22 Much less is known on RSWA in patients with narcolepsy, 5 and in particular, there is still uncertainty as to whether in these patients, the extent of RSWA depends on the concomitant occurrence of RBD. 4 On these bases, we elected to consider RSWA in patients with idiopathic RBD as a clinical benchmark for DNE application in study 2. We made the opposing choice to focus on narcolepsy in study 3, in which we sought to obtain proof of principle that DNE has practical application in studies of RSWA on animal models of human disease. Currently available animal models of Parkinson's disease have limited construct validity and fail to replicate the characteristic pattern of sleep dysfunctions. 21 On the other hand, mice lacking either orexin peptides 8 or the whole orexin neurons 9 are available and have good construct validity for narcolepsy. To our knowledge, the occurrence of RSWA has not been directly investigated in these models. On these bases, in study 3, we tested whether DNE during REM sleep is able to discriminate between orexin-deficient mouse models of narcolepsy 8, 9 and wild-type controls.
METHODS
This study involved the re-analysis of data from 54 human subjects, 8 rats, and 51 mice. Experiments on animals were performed in accordance with the guide for the care and use of laboratory animals of the National Institutes of Health, with protocols approved by local and governmental ethics committees. Human studies received prior approval by the institutional review board, and written informed consent was obtained from each participant.
Subjects and Recordings

Study 1: Comparative Physiology of Muscle Activity During Sleep
The comparative physiology of proximal and limb muscle control during sleep was investigated on previously published datasets of young healthy human subjects 20, 23 (Jr-Ctrls, n = 21, 11 males), wild-type rats 20 (Sprague-Dawley strain, n = 8, all males), and wild-type mice 20 (C57Bl6/J strain, n = 9, all females). Jr-Ctrls were aged 31 ± 1 years and were free of sleep disorders including RBD and the restless legs syndrome. 23 Experiments on rats and mice were originally performed for different research projects at the Neurocenter of Southern Switzerland (Lugano, Switzerland) and the Department of Biomedical and Neuromotor Sciences (University of Bologna, Italy), respectively. At surgery, rats and mice were aged 16-17 weeks and 28 ± 5 weeks and weighted 420 ± 30 g and 23 ± 1 g, respectively. Surgery consisted of the implantation under anesthesia of electrodes for electroencephalographic recordings (ipsilateral fronto-parietal derivation), and 3 pairs of electrodes for differential EMG recordings from the neck muscles and from the TA muscles of each hind limb. The EMG signal from each muscle was recorded with couples of electrodes crafted from fluorocarbon-coated stainless-steel wire (Cooner Wire, Chatsworth, CA; model AS632, diameter 0.38 mm), amplified, and filtered (rats: 3-500 Hz, AURA amplifier, Grass, West Warwick, RI; mice: 10-1000 Hz, 7P511J amplifiers, Grass). 20 After ≥ 1 week's recovery from surgery, rats and mice were recorded for ≥ 24 hours while undisturbed and freely-behaving in their own cages employing a rotating electrical swivel and a counterbalanced suspensor arm. Rats and mice were housed and recorded with a 12:12 hour lightdark cycle. Data analysis for the present study involved the light (rest) period for the sake of comparison with data on the human nighttime period. Rat sleep was scored by trained investigators with a time resolution of 10 seconds. 20 Mouse sleep was scored with a validated open-source algorithm (SCOPRISM) and a time resolution of 4 seconds. 20, 24 Study 2: Discrimination of Patients With Idiopathic RBD Based on Muscle Activity During REM Sleep The capability of DNE during REM sleep to detect RSWA in patients was investigated in a group of patients with idiopathic RBD (n = 20, 17 males, aged 70.7 ± 1.1 years), who were contrasted with a group of age-matched control subjects (Sr-Ctrls, n = 13, 4 males, aged 68.0 ± 2.2 years) as well as with the Jr-Ctrl group of study 1. Patients with idiopathic RBD and Sr-Ctrls belonged to previously published datasets, 15, 25 and recordings and sleep scoring were performed with the same protocol as for Jr-Ctrls.
Study 3: Discrimination of Orexin-Deficient Narcoleptic Mice Based on Muscle Activity During REM Sleep
The potential utility of DNE during REM sleep in studies of RSWA on animal models of human disease was assessed by attempting to discriminate orexin-deficient narcoleptic mice from wild-type mice. This was investigated on five groups of male mice fully congenic to the C57Bl6/J strain. The Jr-TG group (n = 12) consisted of orexin (hypocretin)-ataxin3 transgenic mice, which undergo postnatal loss of orexin neurons because of selective expression of the ataxin3 neurotoxin under control of the orexin (hypocretin) gene promoter. 9 The KO group (n = 8) consisted of orexin (hypocretin) knock-out mice, with congenital loss of orexin (hypocretin) peptides but no loss of hypothalamic neurons. 8 The Jr-WT group (n = 14) consisted of wild-type controls to Jr-TG and KO. The Jr-TG, KO, and Jr-WT mice constituted a previously published dataset, 26 with the addition of 4 Jr-WT mice studied with the same protocol as the others of their group. The mice of the Jr-WT, Jr-TG, and KO groups were aged 14-15 weeks at surgery. The present study also involved the re-analysis of another published dataset 27 of male middle-aged (10-11 months of age at surgery) orexin (hypocretin)-ataxin3 transgenic mice with postnatal loss of orexin (hypocretin) neurons (Sr-TG, n = 9) and of age-matched wild-type controls (Sr-WT, n = 8). All mice included in study 3 were implanted under isoflurane anesthesia with electrodes for EEG recordings and for neck muscle EMG recordings and with a telemetric transducer and catheter for arterial blood pressure measurement (TA11PA-C10, DSI, St. Paul, MN). Recordings were performed with the same protocol as that described for the mice included in study 1, except that EMG was filtered between 100 Hz and 1000 Hz, recovery from surgery was prolonged to 12 days, and the sleep scoring was performed by trained investigators with a time resolution of 4 seconds.
26,27
Distributions of Normalized EMG Values (DNE) DNE was performed with software routines written in Matlab (the Mathworks, Natick, MA). The EMG signals were first rectified (ie, negative EMG values were considered as positive) and averaged (raEMG) with a time resolution of 0.5 seconds. This time resolution was chosen arbitrarily as a compromise between the 1-second time resolution of the REM sleep atonia index (RAI), a well-established polysomnographic index of human RSWA, 15, 28 and the conventional 0.1-second lower threshold duration for the phasic EMG activity during REM sleep in humans. 11, 12 The 0.5-second time resolution chosen for humans was kept the same for rats and mice to provide a unitary time frame for the comparative analysis. The values of raEMG were then normalized (cf. the EMG NORM formula below) for comparison between different species and muscles. In order to decrease the sensitivity of this normalization procedure to signal artifacts, the distribution of raEMG values of each individual during one rest period (ie, one night for human subjects or one light period for rodents) was first trimmed by discarding its bottom 0.5% and its top 0.5% of values. The choice of the 0.5% threshold was arbitrary. For each individual, the normalization procedure consisted in converting the trimmed raEMG distribution into normalized EMG values (EMG NORM ) by subtracting from each raEMG value the minimum value of the trimmed raEMG distribution and by dividing this difference by the range of values of the trimmed raEMG distribution, according to the formula: EMG r aEMG minimum raEMG maximum raEMG minimum raEMG
As a result of this normalization procedure, each muscle of each individual was characterized by a distribution of EMG NORM values that ranged from 0% to 100%, corresponding to the minimum and maximum values, respectively, of the trimmed raEMG distribution. The EMG NORM distribution for the whole recording period was finally split into separate distributions corresponding to the states of wakefulness, NREM sleep, and REM sleep. These three distributions were directly comparable because the normalization procedure (cf. equation above) was performed employing the same parameters (ie, minimum and maximum raEMG values) for each wake-sleep state. An example of DNE on a single animal's data, including distributions of the EMG values, is shown in Supplementary Figure S1 . In order to search for simple indexes of EMG activity, the EMG NORM distributions during wakefulness, NREM sleep, and REM sleep were quantified based on their centiles. The xth centile of a EMG NORM distribution is the EMG NORM value below which x% of the values in the distribution fall. Thus, each centile is computed taking into account all of the values in the distribution. Since the EMG NORM values were computed after raEMG trimming, the centiles of the EMG NORM distributions of each wake-sleep state were independent of the bottom 0.5% and top 0.5% of the raEMG values of the whole rest period. To limit the number of statistical comparisons performed while characterizing the salient features of distributions, the analysis was focused on the following fixed set of centiles: 1, 3, 5, 25, 50, 75, 95, 97, and 99. This choice was arbitrary. The rationale for this choice was to quantify the first quartile (25th centile), the median (50th centile), and the third quartile (75th centile), which are commonly quantified in the form of boxplots. The first, third, and fifth centiles, on the one hand, and the 95th, 97th, and 99th centiles, on the other hand, were also computed to characterize the extremes or "tails" of the distributions. The chosen centile scale was thus symmetrical around the median (50th centile), but had non-uniform intervals between the centiles.
Statistical Analysis
Data were reported as mean ± SEM. Statistical analyses employed repeated-measure or mixed-model analysis of variance (ANOVA) with the general linear model procedure and Huyn-Feldt correction in case of failure of the sphericity assumption, paired-sample t tests, and independent-sample t tests, with significance set at p < .05. The t tests were conducted on a centile-by-centile basis, for example, the 25th centile of neck EMG NORM during NREM sleep versus the 25th centile of neck EMG NORM during REM sleep, etc. In study 2 and study 3, the effectiveness of the discrimination between experimental groups based on a given centile of EMG NORM during REM sleep was assessed with receiver operating characteristic (ROC) functions, which plotted detection sensitivity versus false positive rate (ie, 1-specificity). For comparison, in study 2, a ROC function was also computed based on the RAI, 15, 28 an index of RSWA well established for clinical research, and validated against manual scoring of chin EMG. 4, 29, 30 In study 3, a ROC function was also computed based on the mean value of raEMG over the whole REM sleep time analyzed, similarly to previously published work on RSWA in mice. 18 The linear relationship between the RAI and EMG NORM in study 2 and that between the mean raEMG and EMG NORM in study 3 was evaluated with the Pearson's correlation coefficient. The significance of differences in the ROC AUC in study 2 and study 3 was assessed with the EasyRoc free web tool v. 1.3 (http:// www.biosoft.hacettepe.edu.tr/easyROC/). The other statistical analyses were performed with the SPSS software (SPSS Inc.).
RESULTS
Study 1: Comparative Physiology of Muscle Activity During Sleep
The whole distributions of chin EMG NORM of Jr-Ctrls and of neck EMG NORM of rats and mice were shifted downward during NREM sleep compared to wakefulness (Figure 1 , upper panels). A further downward shift occurred during REM sleep for the whole distributions of chin EMG NORM of Jr-Ctrls and of neck EMG NORM of rats, and for all but the 1st, 3rd, and 25th centiles of neck EMG NORM of mice.
The distributions of EMG NORM of the left and right TA muscles did not differ significantly as a function of the wake-sleep state (Supplementary Figure S2) . Therefore, all further analyses on TA activity were performed on the average EMG NORM of the two TA muscles (avTA) (Figure 1 , lower panels). The distribution of avTA EMG NORM of Jr-Ctrls was independent of the wake-sleep state up to its 50th centile. The 75th, 95th, 97th, and 99th centiles of avTA EMG NORM of Jr-Ctrls were instead higher during wakefulness than during NREM sleep. On the other hand, the distribution of avTA EMG NORM of rats differed significantly between wake-sleep states, with progressive downward shifts from wakefulness to NREM sleep and from NREM sleep to REM sleep, with the only exception of the first centile. The whole distribution of avTA EMG NORM of mice was also shifted downward during NREM sleep compared to wakefulness. Only the 99th centile of avTA EMG NORM of mice was also significantly higher during NREM sleep than during REM sleep.
Study 2: Discrimination of Patients With Idiopathic RBD Based on Muscle Activity During REM Sleep
The distribution of chin EMG NORM during REM sleep was shifted upward in patients with idiopathic RBD compared to Sr-Ctrls except for the first and third centiles (Figure 2 , upper left panel). The distribution of chin EMG NORM during REM sleep was also shifted upward in patients with idiopathic RBD compared to Jr-Ctrls from the 5th to the 97th centile. The 97th and 99th centiles of avTA EMG NORM were significantly higher in The RAI was significantly lower in patients with idiopathic RBD than either in Sr-Ctrls or in Jr-Ctrls at group level, as expected ( Figure 2, upper middle panel) . Lower RAI values significantly discriminated patients with idiopathic RBD from control subjects as a whole (Figure 2, upper right panel) . Each of the chin EMG NORM centiles (ie, 5th to 99th), which differed significantly at group level between patients with idiopathic RBD and either Sr-Ctrls or Jr-Ctrls, provided significant discrimination at individual level between patients with idiopathic RBD and control subjects (Supplementary Table S1 ). The best discrimination was afforded by the 50th centile (median value) of chin EMG NORM, as judged from the AUC value of its ROC function (Figure 2, upper right panel) . This AUC value did not differ significantly from that of the ROC function based on the RAI (p = .593). On the other hand, the 99th centile of avTA EMG NORM also significantly discriminated patients with idiopathic RBD from control subjects as a whole at individual level (Supplementary Table  S1 and Figure 2 , upper right panel), but this discrimination was significantly less effective than that based on the RAI (p = .049). The EMG NORM centiles that afforded the best significant discrimination between experimental groups in terms of ROC AUC (ie, the 50th centile of chin EMG NORM , Figure 2 , lower middle panel, and the 99th centile of avTA EMG NORM , Figure 2 , lower right panel) correlated negatively and significantly with the RAI, albeit with a prominent scatter of the values of patients with idiopathic RBD. The RAI also correlated negatively and significantly (p < .05) with the 25th, 75th, 95th, 97th, and 99th centiles of the chin EMG NORM (Table 1) .
Study 3: Discrimination of Orexin-Deficient Narcoleptic Mice Based on Muscle Activity During REM Sleep
The distributions of neck EMG NORM during wakefulness and NREM sleep did not differ significantly among Jr-TG, Jr-WT, KO, Sr-TG, and Sr-WT mice (Supplementary Figure S3) . During REM sleep, the whole distribution of neck EMG NORM was shifted upward in Jr-TG and KO compared to Jr-WT mice, except for the first centile for KO (Figure 3, upper left panel) . The distribution of neck EMG NORM during REM sleep was also shifted upward in Sr-TG compared to Sr-WT up to its 50th centile ( Figure 3, upper middle panel) . Accordingly, the mean value of raEMG over the whole REM sleep time analyzed was significantly higher in Jr-TG than in Jr-WT (Figure 3 , lower left panel) and in Sr-TG than in Sr-WT (Figure 3 , lower middle panel). Instead, the difference in mean raEMG between KO and Jr-WT was not statistically significant (p = .195, Figure 3 , lower left panel). At individual level, both the 50th centile of neck EMG NORM during REM sleep and the mean raEMG during REM sleep significantly discriminated between orexin (hypocretin) deficient mice and wild-type mice as a whole (Figure 3 , upper right panel). The estimated ROC AUC value based on the 50th centile of neck EMG NORM was higher than that based on the mean raEMG (84 ± 6% vs. 74 ± 7%), but the difference was not statistically significant (p = .273). The mean raEMG during REM sleep correlated positively and significantly (p < .05) with the 50th centile of neck EMG NORM (Figure 3 , lower right panel), as well as with each other EMG NORM centile (Table 2) .
DISCUSSION
In study 1, we developed and applied DNE, a novel automated procedure for EMG normalization and analysis applicable to different muscles and species. With the DNE, we provided evidence that the changes of neck EMG NORM during sleep in wildtype rats and mice validly model those of chin EMG NORM in healthy humans, whereas the effects of sleep on TA EMG NORM differed between rats, mice, and humans. In study 2, with DNE, we discriminated patients with idiopathic RBD from control subjects based on the median chin EMG NORM during REM sleep. In study 3, with the same DNE parameter, only computed on neck instead of chin muscles, we discriminated orexin (hypocretin)-deficient narcoleptic mice from wild-type mice.
In study 1, our finding of progressive reductions of neck EMG NORM of rats, mice, and human subjects from wakefulness to NREM sleep and from NREM sleep to REM sleep (Figure 1 ) demonstrated quantitatively that the control of neck muscles of wild-type rats and mice during sleep validly models the control of chin muscles of healthy human subjects. These data thus support the validity of previous estimates of RSWA based on neck muscle EMG in mice with impaired glycine and GABA A receptor function 18 and rats with GABA B agonist injection in the inferior colliculus. 19 On the other hand, the distribution of avTA EMG NORM in healthy humans was independent of the wake-sleep state except for the occasional occurrence of high EMG NORM values during wakefulness, potentially due to voluntary leg movements. Sleep thus exerted strikingly dissimilar effects on the distributions of chin and avTA EMG NORM in humans, in line with the conventional distinction between chin (axial muscle) activity as mainly "tonic" and TA (segmental muscle) activity as "phasic." However, the distribution of chin EMG NORM during wakefulness overlapped to some extent the distributions during NREM sleep and REM sleep, making the choice of a reference chin muscle "tone" arbitrary. Moreover, the distributions of avTA EMG NORM were not shaped as square waves, as would be expected in the case of discrete EMG bursts with little or no baseline activity, but rather showed increasing values across the distribution centiles. This was not a consequence of the analysis of average TA (avTA) EMG NORM because it occurred also for the EMG NORM distributions of single (left or right) TA muscles (Supplementary Figure S2) . This finding suggests some modulation of the background TA EMG activity akin to muscle tone. Accordingly, avTA EMG NORM of rats was modulated by the wake-sleep states with the same pattern as neck EMG NORM , with progressive downward shifts from wakefulness to NREM sleep and from NREM sleep to REM sleep ( Figure 1, middle panels) . In mice, the whole distribution of avTA EMG NORM also showed a downward shift from wakefulness to NREM sleep, as did the distribution of neck EMG NORM (Figure 1, right panels) . However, the whole distribution of avTA EMG NORM in mice did not further decrease from NREM sleep to REM sleep, with the exception of its rightmost tail (top centile). These differences between rats and mice may have been, at least in part, because rats and mice datasets were obtained in different laboratories for different research projects, and thus differed in terms of time resolution and technique of sleep scoring, age, and sex. Nonetheless, viewed in comparison with data on humans, these results on rodents demonstrated quantitatively that the control of TA muscles of Pearson's linear correlation coefficients (r) between the rapid-eye-movement (REM) sleep atonia index (RAI) and different indexes obtained from distributions of normalized eletromyographic values (DNE) in 20 patients with idiopathic rapid-eye-movement sleep behavior disorder (RBD), 13 age-matched control subjects, and 21 young healthy control subjects. The DNE indexes consisted of the centiles (c) of normalized electromyographic activity (EMG NORM ) of the submentalis (chin) and average tibialis anterior (avTA) muscles during REM sleep. The table shows the results that were not included in Figure 2 .
wild-type rats and mice during sleep does not model validly the control of TA muscles of healthy human subjects. At least in part, this discrepancy may result from differences in sleep posture between bipeds and quadrupeds. The time structure (as opposed to the amplitude) of TA EMG bursts during NREM sleep is instead highly conserved in young healthy human subjects, rats, and mice, with a prevalence of short intervals (<10 seconds) between bursts. 20 Thus, TA EMG recordings in rats and mice may be of greater value for modeling the restless legs syndrome than for modeling RSWA. Because of the way DNE is computed, the conclusions of the present study concern the face validity 31 of the effects of sleep on within-subject distributions of EMG values. The DNE does not yield results on the absolute EMG signals or the physiological events contributing to the EMG itself.
In study 2, a significant discrimination between patients with idiopathic RBD and control subjects was achieved at group level and at individual level (ROC functions) based on the median value (50th centile) of the chin EMG NORM and on the 99th centile of the avTA EMG NORM during REM sleep (Figure 2 , left panels and top right panel). The correlation between either of these DNE indexes and the RAI, which is an established clinical index of RSWA based on automated analysis of chin EMG, 15, 28 was significant but rather weak. Accordingly, the RAI basically reflects the percentage of time spent in REM sleep with chin muscle atonia, 15, 28 whereas our DNE indexes reflected the median amplitude of chin EMG and, essentially, the peak amplitude of TA EMG during REM sleep, respectively.
We found that DNE parameters discriminated patients with idiopathic RBD from control subjects (ROC AUC of 85% and 71% for the median chin EMG NORM and the 99th centile of avTA EMG NORM during REM sleep, respectively; Figure 2 , upper right panel). The subject groups of study 2 were not gender-matched, and it remains an open question whether and to what extent this gender discrepancy affected the findings. Nonetheless, the performance of DNE parameters in discriminating patients with idiopathic RBD did not match those of manual quantification of EMG activity during REM sleep, which were reported with ROC AUC of 99% based on any chin EMG activity and with ROC AUC of 84% based on phasic TA EMG activity. 12 We developed DNE to provide a platform for translational research on RSWA between human subjects and rodent models, and not to substitute for validated clinical indexes specific for human subjects. 12, 15, 28 It should also be remarked that DNE is fully automated. This is a useful feature for a technique designed for translational research because a wide expertise would be needed for accurate manual review of EMG signals. Moreover, manual review of EMG tracings is time consuming, so automated techniques such as DNE lend themselves better to high-throughput preclinical screening studies. As a tradeoff for these advantages, it appears unrealistic that fully automated techniques such as DNE match the performance of expert manual scoring of EMG tracings.
The better discriminative performance of the median chin EMG NORM compared to that of the 99th centile of avTA EMG NORM during REM sleep, taken together with our findings of study 1 that the control of neck muscles during sleep in rodents validly models the control of chin muscles in humans, pointed to the median EMG NORM of chin or neck muscles during REM sleep as a promising index for translational research on RSWA. Study 3 provided proof of principle of this suggestion: the median neck EMG NORM during REM sleep significantly discriminated narcoleptic orexin (hypocretin)-deficient mice from wild-type mice both at group level and at individual level (Figure 3) . The occurrence of RSWA and RBD in patients with narcolepsy with cataplexy (type 1) is well documented. 4, 5, 32 The key pathophysiological feature of human narcolepsy with cataplexy is the loss of functional orexin (hypocretin) neurons. 10 We found that mice lacking either the whole orexin (hypocretin) neurons (Jr-TG and Sr-TG) or only the orexin (hypocretin) peptides (KO) had higher median values of neck EMG NORM distribution during REM sleep compared to wild-type control mice. This finding demonstrates that lack of orexins (hypocretins) per se is sufficient to elicit RSWA, supporting previous clinical inferences in this sense. 32 Although the results of study 2 and 3 were encouraging, the suggestion that increased median EMG NORM of chin (humans) and neck (rodents) muscles may represent a common signature of RSWA in different species and pathological conditions is to be taken as preliminary until replicated in other clinical and preclinical settings. In this respect, it would be interesting to compare with DNE the recordings of a mouse model 33 and a very recent rat model 34, 35 that exhibit RSWA and RBD because of genetic manipulations of pontine neurons. Moreover, further work with DNE is needed to test whether RSWA differs in narcoleptic patients depending on the occurrence of RBD, 4 and whether DNE can uncover subtle signs of RSWA in models of Parkinson's disease even in the absence of clearcut RBD. 21 Further work is needed to understand DNE better as a normal indicator of EMG, beyond its application to conditions like RBD. For example, the first step to compute DNE consists of rectifying and averaging any EMG activity within 0.5 second time windows (cf. Methods). Thus, the DNE does not discriminate formally between tonic and phasic EMG activity patterns, which are well-known features of the EMG during REM sleep in humans (cf. 11, 12 ) and rodents (cf. 18, 19 ). This is a limitation of our proposed technique. Nonetheless, in clinical research, this limitation is shared by the RAI, a validated and automated index of RSWA. 15, [28] [29] [30] Phasic and tonic EMG activity is sometimes difficult to distinguish also with careful manual scoring of EMG tracings, and data indicate that scoring "any" (tonic and/or phasic) measure of chin EMG activity greatly decreases the complexity of the scoring process and is sufficient for RBD diagnosis. 12 It should also be remarked that there is no standard definition of phasic or twitch EMG activity in laboratory rodents. Future research combining DNE with visual scoring of tonic and phasic EMG activity, including muscle twitches or EMG bursts, should test whether these EMG activity patterns are, nonetheless, differently reflected in DNE, particularly in the EMG NORM values across centiles. The answer to this question may differ between species, given that phasic EMG activity during REM sleep is commonly defined as longer than 0.1 second in humans, 11, 12 whereas estimated twitch duration is approximately 20 ms in mice. 18 Transitions into and out from REM sleep may impact on DNE, also considering inter-species differences in the average duration of REM sleep bouts. 20 It is unknown whether and how the DNE of an individual correlates between different times of day (eg, nighttime sleep vs. daytime naps in humans, or sleep in the light vs. the dark period in rodents), between different days, and among multiple recording sites. Figure 3 .
From a more technical viewpoint, it would be useful to test whether and to what extent DNE depends on the hardware employed for recordings, such as electrodes and filters. In this study, we quantified DNE based on an arbitrarily defined set of centiles (cf. Methods). This set was limited in order to limit the number of statistical comparisons performed, and was determined a priori, before inspection of the study results, so as to avoid experimental bias. Therefore, we cannot exclude that other DNE centiles (eg, the 45th or the 98th) would have performed better than those that we tested as translational indexes of RSWA. We also cannot exclude that a suitable cross-centile transformation exists that yields a singular measure of DNE rather than centile-specific indexes, possibly with the inclusion of a suitable EMG calibration to some EMG standard. Further research on DNE may also devise a way of dealing automatically with signal artifacts better than raEMG trimming, which may exclude useful information such as phasic EMG bursts. Furthermore, the raEMG trimming may not eliminate artefacts such as contamination by heartbeat in rodents, which may affect the variability in EMG NORM values across centiles during REM sleep especially. These artefacts may also contribute to explain why the distance between the neck EMG NORM distributions during NREM sleep and REM sleep in rodents was somewhat narrower than the corresponding distance between chin EMG NORM distributions in humans. This may ultimately decrease the sensitivity of RSWA detection by DNE in rodents versus humans.
We developed DNE to strengthen the bases for valid translational models of RSWA by allowing for direct comparison of different muscles and species. The main novel feature of DNE in the context of EMG analysis during sleep is its normalization procedure (cf. the equation in Methods). The centile-based approach to quantify salient features of the whole EMG distributions is, to our knowledge, also novel in this context. By performing extensive analyses on a dataset of 54 human subjects, 8 rats, and 51 mice subdivided in a total of 10 experimental groups, we provided strong evidence that DNE can be applied, with no modification, to chin muscles of human subjects, neck muscles of rats and mice, and TA muscles of humans, rats, and mice. To our knowledge, DNE is the first technique that allows this possibility. This is not a claim that DNE performs better, for a given species and muscle, than any of the different measures of EMG activity during REM sleep previously employed on humans [11] [12] [13] [14] [15] [16] [17] and rodents. 18, 19 An exhaustive comparison between the performance of DNE and that of these measures was outside the scope of the present study. Pilot comparisons between DNE and the RAI, a validated index of RSWA well-established for clinical research, 15, [28] [29] [30] or the mean raEMG, which is akin to previously applied EMG indexes in basic research, 18 indicated significant concordance between methods, as expected.
In conclusion, the results of the present study indicate that control of the neck muscle during sleep in rats and mice validly models the control of chin muscles in human subjects, and that the novel DNE approach that we proposed can have practical applications in translational research on RSWA. In particular, the results indicate that increased median EMG NORM of chin (humans) and neck (rodents) muscles may represent a common signature of RSWA in different species and pathological conditions. Notably, there is a low correlation between human chin EMG and most RBD behaviors during REM sleep. 36 In perspective, combination of DNE with simultaneous video recordings may represent a further step to strengthen translational studies of RSWA and RBD. These studies may increase our understanding of the mechanisms whereby the loss of orexin (hypocretin) neurons leads to RSWA and RBD, and help develop translational models of RSWA and RBD as prodromes of synucleinopathy, in which to test for the effectiveness of neuroprotective treatments.
